awarded as Venture Capital firm of the year by the Global Annual Achievement Awards for Artificial Intelligence, the fund’s ecosystem is supported by a large network of corporate and academic partnerships, as well as other venture funds. To date, Analytics Ventures has attracted $20 million combined to its studio and portfolio companies, which includes CureMetrix—world-class provider of FDA-cleared, AI-based triage software for mammography.

To learn more about Analytics Ventures and the ventures it supports, visit www.analyticsventures.com.

A sample of our recently formed ventures are as follows:

CureMatch - computational DNA analysis for personalized cancer Rx combinations.

Curemetrix - next generation of image analysis for mammography

AlphaTrAI - is an AI-based equity trading platform. The trading algorithm is proprietary in nature and has been built with a one-of-a-kind fusion of the latest AI techniques from concepts of quantum physics and dynamical systems. With three-year back testing results extending into the current volatile trading atmosphere, AlphaTrAI's end-to-end automated trading platform has outperformed the Standard & Poor's (S&P) 500.

Tinoro - is developing the world's fastest and first portable virus and bacteria detection solution.

Dynam.AI - provides enterprises worldwide with end-to-end solutions for Ai needs in the are of detection and forecasting

Kazuhm, Inc. - is a commercialized peer-to-peer data processing solutions provider.

AdTheos, Inc. - is an independent online digital advertising optimization system leveraging machine learning technology.

Specialties: Venture Formation, Seed Investments, Angel Investments, Venture Capital